They also had higher OSDI scores pre-treatment (50.7 ± 5.9 vs 40.8 ± 6.5, p = 0.27), suggesting they were more symptomatic at baseline, though this difference did not reach statistical significance.
1
—
—
They also had higher OSDI scores pre-treatment (50.7 ± 5.9 vs 40.8 ± 6.5, p = 0.27), suggesting they were more symptomatic at baseline, though this difference did not reach statistical significance.